Diabetes News: Breaking Diabetes News, Comments and Articles. - Page: 4

Test to Aid Doctors Diagnose and Monitor Diabetes

A clinical chemistry blood test reflects a person’s average blood-glucose levels over the preceding three months.

Targeting glucagon action: A new frontier for regulating diabetes

For the first time, scientists at the Toronto General Research Institute showed that targeting glucagon action in the brain may be a new frontier for regulating diabetes.

Abbott Diabetes Care: Class 1 Recall - FreeStyle InsuLinx Blood Glucose Meters - Risk of Incorrect Test Result

Audience: Risk Manager, Patient, Health Professional   [Posted 05/20/2013] ISSUE: Abbott initiated a voluntary recall of FreeStyle lnsulinx Blood Glucose Meters in the United States. At extremely high blood glucose levels of 1024 mg/dL and...

Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S.

JERUSALEM, May 17, 2013 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that the United States Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug application(IND) for ORMD-0801, its oral insulin capsule. "We are very pleased to have the FDA clearance to proceed," st...

How To Find Out Your Genetic Risk Factors Like Angelina Jolie Did

SAN FRANCISCO, May 17, 2013 /PRNewswire/ -- When Angelina Jolie told the world about her double mastectomy, she expressed a wish for all women with a family history of breast cancer: "It is my hope that they, too, will be able to get gene tested, and that if they have a high risk they, too, will know that they have strong options." You may think that such a test is something only movie stars...

Transition to Propellant-Free Combivent® Respimat® (ipratropium bromide and albuterol) Inhalation Spray Nears Completion

RIDGEFIELD, Conn., May 17, 2013 /PRNewswire/ -- As part of the company's commitment to chronic obstructive pulmonary disease (COPD) patients, Boehringer Ingelheim Pharmaceuticals, Inc., a leader in respiratory health, is updating healthcare professionals (HCPs) and patients that the transition to COMBIVENT® RESPIMAT® (ipratropium bromide and albuterol) Inhalation Spray for the maintenanc...

Mylan Launches Generic Tricor® Tablets

PITTSBURGH, May 17, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has shipped Fenofibrate Tablets, 48 mg and 145 mg. Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is the generic version of Abbvie Inc.'s Tricor&#...

TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map

BOSTON, May 17, 2013 /PRNewswire/ -- TechAtlas Group has announced the release of the latest update for their competitive landscape map for the Chronic Kidney Disease (CKD) market. This particular landscape highlights over 90 international companies with drugs and devices currently on the market and in development addressing CKD and its sequelae. (Logo:  http://photos.prnewswire.com/pr...

Flax Seasoning Shows How Eating More Vegetables Will Improve Health

Arlington, VA (PRWEB) May 20, 2013 Adding more vegetables to meals is one of the simplest things that can be done to drastically improve health. Vegetables have been shown to help decrease chances of acquiring heart disease, diabetes, and cancer....

Hearing Loss & Diabetes

Recent studies suggest a possible link between diabetes and hearing loss, but more research is still needed.

Chicago Bears Quarterback Jay Cutler in Talks With Bio-Solutions Corp-UPDATE

CHICAGO, ILLINOIS -- (Marketwired) -- 05/20/13 -- Bio-Solutions Corporation (OTCBB: BISU)(PINKSHEETS: BISU) is announcing today that Chicago Bears quarterback Jay Cutler is currently looking over an endorsement deal involving their diabetic product, Type-2 Defense, which is a preventative supplement for people who are diabetic or who are pre-diabetic. This product helps regulate blood sugar and...

Risks, Interventions Identified For Children's GI Health

An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week® (DDW). In one study targeting obesity, researchers at the Cleveland Clin...

Injectable Nanogel Can Monitor Blood-Sugar Levels And Secrete Insulin When Needed

Injectable nanoparticles developed at MIT may someday eliminate the need for patients with Type 1 diabetes to constantly monitor their blood-sugar levels and inject themselves with insulin. The nanoparticles were designed to sense glucose levels in t...

Chicago Bears Quarterback Jay Cutler in Talks With Bio-Solutions Corp.

CHICAGO, ILLINOIS -- (Marketwired) -- 05/20/13 -- (OTCQB: BISU) (PINKSHEETS: BISU) - Chicago Bears quarterback Jay Cutler is currently looking over an endorsement deal proposed by Bio-Solutions Corporation for Type-2 Defense, a preventative supplement for people who are diabetic or even pre-diabetic. This product helps regulate blood sugar levels, especially for people who are insulin-resistant....

Pacific Island Public Health Group Declares Diabetes at Pandemic Proportions

Pacific Island representatives of The National Association of Chronic Disease Directors published a new assessment of extreme health dangers in the region. Atlanta, GA (PRWEB) May 19, 2013 At a May 6th, 2013 meeting organized by the National Council of Asian Pacific Physicians (NCAPIP), the Pacific Chronic Disease Coalition (PCDC), a council of the National Association of Chronic Disease Directo...

Despite Rising Pharmaceutical Industry Interest in Real World Outcomes, Few Patient-Reported Outcomes Are Included in Diabetes Clinical Trials According to a Context Matters/Pfizer Study

NEW ORLEANS, May 20, 2013 (GLOBE NEWSWIRE) -- Despite rising interest in real world outcomes, a recent study performed by Context Matters and Pfizer demonstrates that less than ten percent of diabetes clinical trials conducted in the past decade included patient-reported outcomes (PROs) as part of their protocols. Presented today at the 18th Annual International Society for Pharmacoeconomics an...

Discovery of a novel medicine for the treatment of chronic wounds

(Umea University) Every 20 seconds, a limb is lost as a consequence of a diabetic foot ulcer that does not heal. To date, medical solutions that can change this situation are very limited. In his doctoral thesis, Yue Shen from the Industrial Doctoral...

Hypothalamic glucagon signaling inhibits hepatic glucose production

Glucagon has traditionally been thought to act exclusively on the liver to promote endogenous glucose production in that organ. Tony Lam and his colleagues now show that it also acts on the hypothalamus to inhibit glucose production through a neural...

Oramed Sweeps Past Worldwide Giants With The First Trial Of Orally Delivered Insulin

BySharon di Stefano:A hallmark disease of an overweight, desk bound nation, diabetes instigates a staggering economic burden on our healthcare system where total costs, including hospital inpatient care, doctor visits, medication, and reduced or lost productivity have been estimated at $245 billion in 2012, a 41% increase in the last five years. Further, diabetes costs the average sufferer $13,700...

Novel approach to regulating blood sugar levels in the body

For the first time, scientists showed that targeting glucagon action in the brain may be a new frontier for regulating diabetes.

UnitedHealthcare IRONKIDS Florida Energizes Youth About Healthy Living Through “IRONMAN” Races

The UnitedHealthcare IRONKIDS Florida event raced around Lake Eva Park today. Thomas Moore from UnitedHealthcare of Florida, and Patrick McGee, IRONKIDS Race Director kicked-off the triathlon’s pool swim, bike course and run aimed to help stem the rising tide of childhood obesity through exercise and healthy lifestyles. Students from Lake Orienta an...

BIBA fever as Blackpool firm wins three finalist places

An SMO business has reached the final shortlist in Lancashire’s premier business awards.MAC Clinical Research, based in the Bispham area of Blackpool, have been finalised in a hat-trick of categories including Creative Business, E-Business and...

Why MannKind's Afrezza Will Succeed Where Pfizer Failed

ByCory Renauer:According to the American Diabetes Association over 25 million people in the US alone have diabetes and the numbers keep on growing. Although insulin injections have come a long way, poking yourself with a needle in public still draws unwanted attention. MannKind Corporation (MNKD) is on the cusp of releasing an inhalable insulin treatment, Afrezza, that promises to revolutionize th...

Statins May Reduce Exercise Benefits For Obese Adults

Statins, the most widely prescribed drugs worldwide, are often suggested to lower cholesterol and prevent heart disease in individuals with obesity, diabetes and metabolic syndrome, which is a combination of medical disorders including excess body fa...

Newer class of diabetes medications may also improve cardiovascular health, researchers report

A newer class of medications used to control blood sugar levels in type 2 diabetics may also improve cardiovascular health, researchers from The Ohio State University Wexner Medical Center reported in a new meta-analysis presented yesterday at the Am...